These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36072422)

  • 1. Pulmonary arterial hypertension sensitive to calcium channel blocker, but not advanced pulmonary hypertension treatment: a case report.
    Hirakawa K; Aoki T; Tsuji A; Ogo T
    Eur Heart J Case Rep; 2022 Sep; 6(9):ytac351. PubMed ID: 36072422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium channel blockers in patients with pulmonary arterial hypertension receiving PAH-specific treatment.
    Hirakawa K; Asano R; Ueda J; Aoki T; Tsuji A; Ogo T
    Int J Cardiol; 2024 Jul; 406():132043. PubMed ID: 38614366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive Vasoreactivity Testing in Pulmonary Arterial Hypertension: Therapeutic Consequences, Treatment Patterns, and Outcomes in the Modern Management Era.
    Gerhardt F; Fiessler E; Olsson KM; Kayser MZ; Kovacs G; Gall H; Ghofrani HA; Badr Eslam R; Lang IM; Benjamin N; Grünig E; Halank M; Lange TJ; Ulrich S; Leuchte H; Held M; Klose H; Ewert R; Wilkens H; Pizarro C; Skowasch D; Wissmüller M; Hellmich M; Olschewski H; Hoeper MM; Rosenkranz S
    Circulation; 2024 May; 149(20):1549-1564. PubMed ID: 38606558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute Vasodilator Response in Pediatric Pulmonary Arterial Hypertension: Current Clinical Practice From the TOPP Registry.
    Douwes JM; Humpl T; Bonnet D; Beghetti M; Ivy DD; Berger RM;
    J Am Coll Cardiol; 2016 Mar; 67(11):1312-23. PubMed ID: 26988953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of calcium channel blockers for the treatment of pulmonary arterial hypertension: How much do we actually know and how could they be positioned today?
    Medarov BI; Judson MA
    Respir Med; 2015 May; 109(5):557-64. PubMed ID: 25666253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sildenafil versus nitric oxide for acute vasodilator testing in pulmonary arterial hypertension.
    Milger K; Felix JF; Voswinckel R; Sommer N; Franco OH; Grimminger F; Reichenberger F; Seeger W; Ghofrani HA; Gall H
    Pulm Circ; 2015 Jun; 5(2):305-12. PubMed ID: 26064455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute Vasoreactivity Testing and Outcomes in Pulmonary Arterial Hypertension: A Call for Increased Testing.
    Chandrasekara S; Lau EM; Anderson J; Collins N; Cordina R; Corrigan C; Dwyer N; Feenstra J; Horrigan M; Keogh A; Kotlyar E; Lavender M; McWilliams T; Rhodes B; Steele P; Strange G; Thakkar V; Weintraub R; Whitford H; Whyte K; Williams T; Wrobel J; Keating DT;
    Heart Lung Circ; 2023 Feb; 32(2):156-165. PubMed ID: 36503731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Study of Acute Vasoreactivity Testing in Patients with Chronic Thromboembolic Pulmonary Hypertension.
    Xu QX; Yang YH; Geng J; Zhai ZG; Gong JN; Li JF; Tang X; Wang C
    Chin Med J (Engl); 2017 Feb; 130(4):382-391. PubMed ID: 28218209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The long-term response to treatment with calcium channel blockers in a patient with idiopathic pulmonary arterial hypertension.
    Solik P; Lesny P; Luknar M; Varga I; Goncalvesova E
    Bratisl Lek Listy; 2013; 114(5):283-6. PubMed ID: 23611052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-based pharmacologic management of pulmonary arterial hypertension.
    Benedict N; Seybert A; Mathier MA
    Clin Ther; 2007 Oct; 29(10):2134-53. PubMed ID: 18042471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension.
    Sitbon O; Humbert M; Jaïs X; Ioos V; Hamid AM; Provencher S; Garcia G; Parent F; Hervé P; Simonneau G
    Circulation; 2005 Jun; 111(23):3105-11. PubMed ID: 15939821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic effect of iloprost inhalation and oral sildenafil during acute vasoreactivity test in pulmonary arterial hypertension.
    Sompradeekul S; Wattanasiriphakdee S
    J Med Assoc Thai; 2015 Feb; 98(2):144-9. PubMed ID: 25842794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension.
    Sitbon O; Humbert M; Jagot JL; Taravella O; Fartoukh M; Parent F; Herve P; Simonneau G
    Eur Respir J; 1998 Aug; 12(2):265-70. PubMed ID: 9727772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted therapies in pulmonary arterial hypertension.
    Montani D; Chaumais MC; Guignabert C; Günther S; Girerd B; Jaïs X; Algalarrondo V; Price LC; Savale L; Sitbon O; Simonneau G; Humbert M
    Pharmacol Ther; 2014 Feb; 141(2):172-91. PubMed ID: 24134901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twelve-Year Survival in a Patient With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension on Nifedipine Monotherapy.
    Helgeson SA; Enderby CY; Moss JE; Gass JM; Zeiger TK; Burger CD
    Mayo Clin Proc Innov Qual Outcomes; 2019 Sep; 3(3):376-379. PubMed ID: 31485576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathways and Drugs in Pulmonary Arterial Hypertension - Focus on the Role of Endothelin Receptor Antagonists.
    Madonna R; Cocco N; De Caterina R
    Cardiovasc Drugs Ther; 2015; 29(5):469-79. PubMed ID: 26145170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case report: Pathological differences in pulmonary arterial hypertension in long-term responders to calcium channel blockers.
    Tamura Y; Lkhagvadorj S; Tamura Y; Furukawa A; Aida S; Ebinuma H; Shiomi T
    Front Cardiovasc Med; 2023; 10():1295718. PubMed ID: 38028466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute vasoreactivity testing with nicardipine in patients with pulmonary arterial hypertension.
    Saito Y; Nakamura K; Miyaji K; Akagi S; Mizoguchi H; Ogawa A; Fuke S; Fujio H; Kiyooka T; Nagase S; Kohno K; Morita H; Kusano KF; Matsubara H; Ohe T; Ito H
    J Pharmacol Sci; 2012; 120(3):206-12. PubMed ID: 23117888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete therapeutical approach in pulmonary arterial hypertension: from vasodilators to lung transplantation - case report.
    Constantinescu T; Bogdan MA
    Maedica (Bucur); 2014 Jun; 9(2):198-203. PubMed ID: 25705279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Long-Term Response to Treatment with Calcium Channel Blockers in Patients with Idiopathic Pulmonary Arterial Hypertension.
    Kiani A; Omidvar R; Naderi N; Taghavi S; Mirtajaddini M
    J Tehran Heart Cent; 2023 Jan; 18(1):62-67. PubMed ID: 37252215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.